Testing of a new type of drug for the treatment of osteoporosis
found that it reduced fracture risk, though it has not yet been
compared to the other osteoporosis medications already available.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.